FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4379600908> ?p ?o ?g. }

• W4379600908 abstract "The clinical profile and outcomes of patients with Coronavirus Disease 2019 (COVID-19) who require veno-arterial extracorporeal membrane oxygenation (VA-ECMO) or veno-arterial-venous extracorporeal membrane oxygenation (VAV-ECMO) are poorly understood. We aimed to describe the characteristics and outcomes of these patients and to identify predictors of both favourable and unfavourable outcomes.ECMOSARS is a multicentre, prospective, nationwide French registry enrolling patients who require veno-venous extracorporeal membrane oxygenation (ECMO)/VA-ECMO in the context of COVID-19 infection (652 patients at 41 centres). We focused on 47 patients supported with VA- or VAV-ECMO for refractory cardiogenic shock.The median age was 49. Fourteen percent of patients had a prior diagnosis of heart failure. The most common aetiologies of cardiogenic shock were acute pulmonary embolism (30%), myocarditis (28%) and acute coronary syndrome (4%). Extracorporeal cardiopulmonary resuscitation (E-CPR) occurred in 38%. In-hospital survival was 28% in the whole cohort, and 43% when E-CPR patients were excluded. ECMO cannulation was associated with significant improvements in pH and FiO2 on day 1, but non-survivors showed significantly more severe acidosis and higher FiO2 than survivors at this point (P = 0.030 and P = 0.006). Other factors associated with death were greater age (P = 0.02), higher body mass index (P = 0.03), E-CPR (P = 0.001), non-myocarditis aetiology (P = 0.02), higher serum lactates (P = 0.004), epinephrine (but not noradrenaline) use before initiation of ECMO (P = 0.003), haemorrhagic complications (P = 0.001), greater transfusion requirements (P = 0.001) and more severe Survival after Veno-Arterial ECMO (SAVE) and Sonographic Assessment of Intravascular Fluid Estimate (SAFE) scores (P = 0.01 and P = 0.03).We report the largest focused analysis of VA- and VAV-ECMO recipients in COVID-19. Although relatively rare, the need for temporary mechanical circulatory support in these patients is associated with poor prognosis. However, VA-ECMO remains a viable solution to rescue carefully selected patients. We identified factors associated with poor prognosis and suggest that E-CPR is not a reasonable indication for VA-ECMO in this population." @default.
• W4379600908 created "2023-06-08" @default.
• W4379600908 creator A5001725748 @default.
• W4379600908 creator A5003963641 @default.
• W4379600908 creator A5008352636 @default.
• W4379600908 creator A5009221246 @default.
• W4379600908 creator A5009841724 @default.
• W4379600908 creator A5011414084 @default.
• W4379600908 creator A5013698146 @default.
• W4379600908 creator A5014944586 @default.
• W4379600908 creator A5017417878 @default.
• W4379600908 creator A5019241162 @default.
• W4379600908 creator A5038449336 @default.
• W4379600908 creator A5040091356 @default.
• W4379600908 creator A5045570650 @default.
• W4379600908 creator A5047370056 @default.
• W4379600908 creator A5050934960 @default.
• W4379600908 creator A5051550485 @default.
• W4379600908 creator A5063857751 @default.
• W4379600908 creator A5069871091 @default.
• W4379600908 creator A5080659892 @default.
• W4379600908 creator A5081282352 @default.
• W4379600908 creator A5084309719 @default.
• W4379600908 creator A5085940796 @default.
• W4379600908 date "2023-06-06" @default.
• W4379600908 modified "2023-10-18" @default.
• W4379600908 title "Veno-Arterial Extracorporeal Membrane Oxygenation for Circulatory Failure in COVID-19 Patients: Insights from the ECMOSARS Registry" @default.
• W4379600908 cites W2104774046 @default.
• W4379600908 cites W2131907385 @default.
• W4379600908 cites W2900799440 @default.
• W4379600908 cites W3089328061 @default.
• W4379600908 cites W3093590865 @default.
• W4379600908 cites W3106571590 @default.
• W4379600908 cites W3118135981 @default.
• W4379600908 cites W3124069563 @default.
• W4379600908 cites W3124266818 @default.
• W4379600908 cites W3127129273 @default.
• W4379600908 cites W3132566330 @default.
• W4379600908 cites W3134724323 @default.
• W4379600908 cites W3155073785 @default.
• W4379600908 cites W3156398560 @default.
• W4379600908 cites W3158523766 @default.
• W4379600908 cites W3159846254 @default.
• W4379600908 cites W3183983384 @default.
• W4379600908 cites W3202915227 @default.
• W4379600908 cites W4206661876 @default.
• W4379600908 cites W4210548472 @default.
• W4379600908 cites W4210873601 @default.
• W4379600908 cites W4213177646 @default.
• W4379600908 cites W4214814910 @default.
• W4379600908 cites W4214865357 @default.
• W4379600908 cites W4223451229 @default.
• W4379600908 cites W4226497332 @default.
• W4379600908 cites W4285088224 @default.
• W4379600908 doi "https://doi.org/10.1093/ejcts/ezad229" @default.
• W4379600908 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37280062" @default.
• W4379600908 hasPublicationYear "2023" @default.
• W4379600908 type Work @default.
• W4379600908 citedByCount "0" @default.
• W4379600908 crossrefType "journal-article" @default.
• W4379600908 hasAuthorship W4379600908A5001725748 @default.
• W4379600908 hasAuthorship W4379600908A5003963641 @default.
• W4379600908 hasAuthorship W4379600908A5008352636 @default.
• W4379600908 hasAuthorship W4379600908A5009221246 @default.
• W4379600908 hasAuthorship W4379600908A5009841724 @default.
• W4379600908 hasAuthorship W4379600908A5011414084 @default.
• W4379600908 hasAuthorship W4379600908A5013698146 @default.
• W4379600908 hasAuthorship W4379600908A5014944586 @default.
• W4379600908 hasAuthorship W4379600908A5017417878 @default.
• W4379600908 hasAuthorship W4379600908A5019241162 @default.
• W4379600908 hasAuthorship W4379600908A5038449336 @default.
• W4379600908 hasAuthorship W4379600908A5040091356 @default.
• W4379600908 hasAuthorship W4379600908A5045570650 @default.
• W4379600908 hasAuthorship W4379600908A5047370056 @default.
• W4379600908 hasAuthorship W4379600908A5050934960 @default.
• W4379600908 hasAuthorship W4379600908A5051550485 @default.
• W4379600908 hasAuthorship W4379600908A5063857751 @default.
• W4379600908 hasAuthorship W4379600908A5069871091 @default.
• W4379600908 hasAuthorship W4379600908A5080659892 @default.
• W4379600908 hasAuthorship W4379600908A5081282352 @default.
• W4379600908 hasAuthorship W4379600908A5084309719 @default.
• W4379600908 hasAuthorship W4379600908A5085940796 @default.
• W4379600908 hasConcept C126322002 @default.
• W4379600908 hasConcept C164705383 @default.
• W4379600908 hasConcept C2776850375 @default.
• W4379600908 hasConcept C2776858399 @default.
• W4379600908 hasConcept C2780875844 @default.
• W4379600908 hasConcept C42219234 @default.
• W4379600908 hasConcept C500558357 @default.
• W4379600908 hasConcept C71924100 @default.
• W4379600908 hasConceptScore W4379600908C126322002 @default.
• W4379600908 hasConceptScore W4379600908C164705383 @default.
• W4379600908 hasConceptScore W4379600908C2776850375 @default.
• W4379600908 hasConceptScore W4379600908C2776858399 @default.
• W4379600908 hasConceptScore W4379600908C2780875844 @default.
• W4379600908 hasConceptScore W4379600908C42219234 @default.
• W4379600908 hasConceptScore W4379600908C500558357 @default.
• W4379600908 hasConceptScore W4379600908C71924100 @default.
• W4379600908 hasIssue "3" @default.
• W4379600908 hasLocation W43796009081 @default.

• next